ArticleACG case reports journal2026
Nirmatrelvir-Ritonavir-Induced Pancreatitis: A Concern in the COVID Era.
Article in ACG case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The World Health Organization reports that more than 500 drugs can cause drug-induced pancreatitis. Nirmatrelvir-ritonavir (Paxlovid; Pfizer, Mission, KS) has been approved to prevent hospitalization and mortality among patients with COVID-19. A 71-year-old man presented with epigastric abdominal pain and weight loss after recently completing a 5-day course of nirmatrelvir-ritonavir. He was found to have acute pancreatitis which resolved with symptomatic treatment. Nirmatrelvir-ritonavir is a commonly used medication for the treatment of COVID-19. Ritonavir has been identified as 1 potential drug, which can cause pancreatitis. Our case report raises the awareness of the rare complication of pancreatitis from nirmatrelvir-ritonavir.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.